Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study

Sorafenib therapy improves overall survival (OS) in patients with FLT3 internal tandem duplication (ITD) acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation. We explored the efficacy of sorafenib therapy in this population with different concomitant genetic pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ruoyang, Zhang, Yu, He, Jinping, Huang, Fen, Fan, Zhiping, Yang, Kaibo, Xu, Yajing, Xu, Na, Luo, Yi, Deng, Lan, Zhang, Xi, Chen, Jia, Han, Mingzhe, Li, Xudong, Yu, Sijian, Liu, Hui, Liang, Xinquan, Luo, Xiaodan, Shi, Pengcheng, Wang, Zhixiang, Jiang, Ling, Zhou, Xuan, Lin, Ren, Chen, Yan, Tu, Sanfang, Sun, Jing, Wang, Yu, Liu, Qifa, Xuan, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499827/
https://www.ncbi.nlm.nih.gov/pubmed/37704613
http://dx.doi.org/10.1038/s41392-023-01614-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499827/
https://www.ncbi.nlm.nih.gov/pubmed/37704613
http://dx.doi.org/10.1038/s41392-023-01614-1

Ejemplares similares